3rd Meeting of the Hepatitis B and C Network
On the third meeting of the Hepatitis B and C Network national focal points and experts discussed the enhanced surveillance programme for hepatitis B and C across Europe and explored ways of improving it.
Sessions focused on countries‘ experiences, emerging trends, prevalence studies and surveillance. It was also an opportunity to review ECDC’s work and determine future priorities for the surveillance, prevention and control of these two diseases.
Participants included nominated contact/focal points of the 31 EU/EEA countries, experts from ECDC and WHO Regional Office for Europe, the European Commission, the Viral Hepatitis Prevention Board (VHPB), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), WHO headquarters, European Association for the Study of the Liver (EASL), the European Liver Patients Association (ELPA) and representatives from the civil society.
The first meeting of the European network for hepatitis B and C took place in Stockholm in March 2011. From 2011 onwards, ECDC implemented enhanced surveillance for hepatitis B and C across EU/EEA countries with the collection of case-based notification data using revised case definitions and an extended set of disease-specific variables.
Retirement symposium on public health microbiology, celebrating the career of Marc Struelens
17 Sep 2020 to 17 Sep 2020 - Public health microbiology: from managing antimicrobial resistance to COVID-19 - Celebrating the career of Marc Struelens
World Hepatitis Day 2020
28 Jul 2020 to 28 Jul 2020 - ECDC coordinates the enhanced surveillance for hepatitis A, B and C to help countries define epidemiological trends or transmission patterns among newly diagnosed cases. World Hepatitis Day on 28 July provides an opportunity each year to increase the awareness and understanding of viral hepatitis.
Spring European Testing Week 2020
15 May 2020 to 22 May 2020 - European Testing Week is a European campaign that encourages partner organisations, in community, health care and policy institutions, throughout Europe to unite for one week twice a year to increase testing efforts and promote awareness on the benefits of earlier hepatitis and HIV testing.